197 related articles for article (PubMed ID: 28052327)
1. Tissue disruption increases stochastic gene expression thus producing tumors: Cancer initiation without driver mutation.
Capp JP
Int J Cancer; 2017 Jun; 140(11):2408-2413. PubMed ID: 28052327
[TBL] [Abstract][Full Text] [Related]
2. [Stochastic phenomena and the tumoral process].
Capp JP
Med Sci (Paris); 2014; 30(6-7):693-8. PubMed ID: 25014464
[TBL] [Abstract][Full Text] [Related]
3. Stochastic gene expression, disruption of tissue averaging effects and cancer as a disease of development.
Capp JP
Bioessays; 2005 Dec; 27(12):1277-85. PubMed ID: 16299757
[TBL] [Abstract][Full Text] [Related]
4. The epigenomics of cancer.
Jones PA; Baylin SB
Cell; 2007 Feb; 128(4):683-92. PubMed ID: 17320506
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic changes in tumor microenvironment.
Dey P
Indian J Cancer; 2011; 48(4):507-12. PubMed ID: 22293269
[TBL] [Abstract][Full Text] [Related]
6. Altered primary chromatin structures and their implications in cancer development.
Ferraro A
Cell Oncol (Dordr); 2016 Jun; 39(3):195-210. PubMed ID: 27007278
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic regulation of cancer stem cell gene expression.
Bapat SA
Subcell Biochem; 2013; 61():419-34. PubMed ID: 23150261
[TBL] [Abstract][Full Text] [Related]
8. Stem cell plasticity in development and cancer: epigenetic origin of cancer stem cells.
Shah M; Allegrucci C
Subcell Biochem; 2013; 61():545-65. PubMed ID: 23150267
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic changes in cancer.
Iacobuzio-Donahue CA
Annu Rev Pathol; 2009; 4():229-49. PubMed ID: 18840073
[TBL] [Abstract][Full Text] [Related]
10. [Prevention of cancer and the dose-effect relationship: the carcinogenic effects of ionizing radiations].
Tubiana M
Cancer Radiother; 2009 Jul; 13(4):238-58. PubMed ID: 19539515
[TBL] [Abstract][Full Text] [Related]
11. Mutation-selection balance and compensatory mechanisms in tumour evolution.
Persi E; Wolf YI; Horn D; Ruppin E; Demichelis F; Gatenby RA; Gillies RJ; Koonin EV
Nat Rev Genet; 2021 Apr; 22(4):251-262. PubMed ID: 33257848
[TBL] [Abstract][Full Text] [Related]
12. Microenvironmental regulation of cancer stem cell phenotypes.
Quail DF; Taylor MJ; Postovit LM
Curr Stem Cell Res Ther; 2012 May; 7(3):197-216. PubMed ID: 22329582
[TBL] [Abstract][Full Text] [Related]
13. [Models of oncogenesis: an endless world?].
Larsen CJ
Bull Cancer; 2013 Jun; 100(6):555-60. PubMed ID: 23719507
[TBL] [Abstract][Full Text] [Related]
14. Frequent silencing of RASSF1A via promoter methylation in follicular thyroid hyperplasia: a potential early epigenetic susceptibility event in thyroid carcinogenesis.
Brown TC; Juhlin CC; Healy JM; Prasad ML; Korah R; Carling T
JAMA Surg; 2014 Nov; 149(11):1146-52. PubMed ID: 25229773
[TBL] [Abstract][Full Text] [Related]
15. Normal Somatic Mutations in Cancer Transformation.
Wijewardhane N; Dressler L; Ciccarelli FD
Cancer Cell; 2021 Feb; 39(2):125-129. PubMed ID: 33220180
[TBL] [Abstract][Full Text] [Related]
16. The Fate of Th17 Cells is Shaped by Epigenetic Modifications and Remodeled by the Tumor Microenvironment.
Renaude E; Kroemer M; Loyon R; Binda D; Borg C; Guittaut M; Hervouet E; Peixoto P
Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32121394
[TBL] [Abstract][Full Text] [Related]
17. Stochastic gene expression stabilization as a new therapeutic strategy for cancer.
Capp JP
Bioessays; 2012 Mar; 34(3):170-3. PubMed ID: 22231918
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
[TBL] [Abstract][Full Text] [Related]
19. [Aberrant expression of sox2 gene in malignant gliomas].
Volnitskiĭ AV; Semenova EV; Shtam TA; Kovalev RA; Filatov MV
Tsitologiia; 2014; 56(7):504-10. PubMed ID: 25696994
[TBL] [Abstract][Full Text] [Related]
20. Genetic and epigenetic heterogeneity in cancer: a genome-centric perspective.
Heng HH; Bremer SW; Stevens JB; Ye KJ; Liu G; Ye CJ
J Cell Physiol; 2009 Sep; 220(3):538-47. PubMed ID: 19441078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
